OFFICIAL SOURCE FACTS / REQUIREMENT FRAMEWORK
What you need to know
- WHO states that portal use is mandatory from 11 May 2026 for processes handled through ePQS, with stated exceptions for contraceptive devices and snake venom antidotes.
- Functions include submitting applications, responding to information requests, secure document handling, eCTD filing and monitoring pending activities.
What changed
WHO states mandatory portal use from 11 May 2026, subject to the published exceptions.
This summary is not a complete regulatory checklist. Applicability, conditions and exclusions remain governed by the original official document.
Who is affected
- Manufacturers
- Suppliers / Wholesale Distributors
- Exporters
- Regulatory Teams
- Quality Teams
- Business Development
- Procurement Teams
PHARMA GATE INTERPRETATION — NOT AN OFFICIAL REQUIREMENT
Pharma Gate Intelligence
Check the official portal scope before planning a submission. Pharma Gate provides navigation and does not submit applications to WHO.
Business impact
Product-specific evidence and supplier requirements can affect planning and participation. Neither national authorization nor an award is guaranteed.
RECOMMENDED ACTION — NOT A REGULATORY DETERMINATION
What to check
- Whether the product / process is supported by ePQS
- Current exceptions and account instructions
- Applicable filing guidance; portal use does not itself establish a universal mandatory eCTD deadline
Recommended next step
Review the applicable current WHO documents and the specific product or procurement notice with qualified professional support.
- Portal scope / exceptions
- Official access instructions
- Application and document preparation
- WHO portal process
NEXT STEP
Need professional support?
Independent professional support pathways. Pharma Gate does not assess eligibility, certify suppliers or submit applications to WHO.
